Exact Sciences Announces Fourth Quarter 2024 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. TMUS
7. SPY
8. CVS
9. UNH
10. AXP

Go back to Exact Sciences Announces Fourth Quarter 2024 Results

Exact Sciences (EXAS) PT Lowered to $65 at BTIG

February 20, 2025 6:47 AM EST

BTIG analyst Mark Massaro lowered the price target on Exact Sciences (NASDAQ: EXAS) to $65.00 (from $75.00) while maintaining a Buy rating.

The analyst comments "Consistent with the company's pre-announce last month, EXAS delivered a modest Q4 revenue beat, as screening and precision oncology in 2024 grew +13% and +4% Y/Y, respectively. In... More

Exact Sciences (EXAS) Tops Q4 EPS by 27c, Offers Guidance

February 19, 2025 4:09 PM EST

Exact Sciences (NASDAQ: EXAS) reported Q4 EPS of ($0.06), $0.27 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $713.4 million versus the consensus estimate of $694.92 million.

GUIDANCE:

Exact Sciences sees FY2025 revenue of $3.03-3.09 billion, versus the consensus... More